Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS safety_alert · 2014-02-06

Clinical Trial Update: Hepatitis B Virus Reactivation After Withdrawal of Preemptive Antiviral Therapy in Hematologic Malignancy

View source ↗

Summary

The update reports hepatitis B virus reactivation after withdrawal of preemptive antiviral therapy in patients with hematologic malignancies, underscoring safet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Seoul St. Mary's Hospital | Conditions: Lymphoma, Chronic Hepatitis B | Status: UNKNOWN